Browse Pet Safety Reports
16,698 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 16,698 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product, widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 16,698 FDA veterinary adverse event reports for Human.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Jul 1, 2017 | Human | Unknown | Sanguinaria Canadensis Root; Zinc | Skin swelling; Increased heart rate; Irregular pulse; Excessive sweating; Fee... | Outcome Unknown |
| Jun 29, 2017 | Human | Unknown | Ivermectin | Injection site lesion; Accidental exposure | Recovered/Normal |
| Jun 28, 2017 | Human | Unknown | Afoxolaner | Burning sensation (skin); Rash; Blistering (see also Application site SOC); P... | Outcome Unknown |
| Jun 27, 2017 | Human | Unknown | Nitenpyram | Dizzy spell; Flushing | Recovered/Normal |
| Jun 27, 2017 | Human | Unknown | Doramectin | Injection site swelling; Injection site pain; Injection site reddening; Injec... | Outcome Unknown |
| Jun 27, 2017 | Human | Unknown | Device: Syringe | Puncture wound; Accidental exposure; Device Defective NOS | Recovered/Normal |
| Jun 26, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Dispenser, Abnormal; Difficulty of Use | Ongoing |
| Jun 24, 2017 | Human | Unknown | Pergolide Mesylate | Vomiting | Outcome Unknown |
| Jun 23, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Containers, Leaking; Difficulty of Use; Dis... | Recovered/Normal |
| Jun 22, 2017 | Human | Unknown | Afoxolaner | Itching; Rash | Outcome Unknown |
| Jun 20, 2017 | Human | Unknown | Carprofen | Eye irritation | Outcome Unknown |
| Jun 20, 2017 | Human | Unknown | Oclacitinib Maleate | Diarrhoea | Outcome Unknown |
| Jun 19, 2017 | Human | Unknown | Doramectin | Injection site swelling; Injection site skin discolouration; Injection site l... | Outcome Unknown |
| Jun 19, 2017 | Human | Unknown | Polysulfated Glycosaminoglycan | Injection site swelling; Injection site tingling | Recovered/Normal |
| Jun 18, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS | Ongoing |
| Jun 18, 2017 | Human | Unknown | Moxidectin | Nausea; Musculoskeletal pain; Accidental exposure | Outcome Unknown |
| Jun 18, 2017 | Human | Unknown | Imidacloprid; Moxidectin | Pruritus; Erythema (for urticaria see Immune SOC) | Recovered/Normal |
| Jun 16, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS | Ongoing |
| Jun 16, 2017 | Human | Unknown | Afoxolaner | Neurological signs NOS | Outcome Unknown |
| Jun 15, 2017 | Human | Unknown | Selamectin | Localised numbness (see also application site SOC) | Outcome Unknown |
| Jun 13, 2017 | Human | Unknown | Device: Syringe | Device Defective NOS; Injury associated with device | Recovered/Normal |
| Jun 12, 2017 | Human | Unknown | Praziquantel; Emodepside | Throat irritation; Dry mouth | Recovered/Normal |
| Jun 12, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Headache; Containers, Leaking; Difficulty of Use; Dispenser, Abnormal; Produc... | Ongoing |
| Jun 12, 2017 | Human | Unknown | Imidacloprid; Moxidectin | Nausea; Diarrhoea; Accidental exposure | Outcome Unknown |
| Jun 12, 2017 | Human | Unknown | Ivermectin | Fever; Nausea; Fatigue; Accidental exposure | Recovered/Normal |
| Jun 10, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS | Ongoing |
| Jun 10, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS | Recovered/Normal |
| Jun 10, 2017 | Human | Unknown | Enrofloxacin | Injection site swelling; Injection site pain; Injection site numbness | Outcome Unknown |
| Jun 10, 2017 | Human | Unknown | Enrofloxacin | Injection site lesion; Injection site erythema; Injection site itching; Injec... | Outcome Unknown |
| Jun 9, 2017 | Human | Unknown | Insulin Injectable Vial | Hyperglycaemia | Recovered/Normal |
| Jun 8, 2017 | Human | Unknown | Milbemycin Oxime | Tingling sensation | Ongoing |
| Jun 8, 2017 | Human | Unknown | Thiamazole | Diarrhoea; Abdominal cramp | Outcome Unknown |
| Jun 7, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS | Recovered/Normal |
| Jun 7, 2017 | Human | Unknown | Ivermectin 10 Mg/Ml Solution For Inje... | Injection site swelling | Outcome Unknown |
| Jun 6, 2017 | Human | Unknown | Spinosad; Milbemycin Oxime | Tingling sensation; Accidental exposure | Outcome Unknown |
| Jun 6, 2017 | Human | Unknown | Ivermectin 10 Mg/Ml Solution For Inje... | Injection site inflammation | Outcome Unknown |
| Jun 6, 2017 | Human | Unknown | Enrofloxacin; Silver Sulfadiazine | Eye irritation | Outcome Unknown |
| Jun 5, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Dispenser, Abnormal | Ongoing |
| Jun 5, 2017 | Human | Unknown | Tulathromycin | Injection site reaction NOS | Outcome Unknown |
| Jun 4, 2017 | Human | Unknown | Tildipirosin Injectable | Injection site self trauma | Outcome Unknown |
| Jun 2, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Application site burning sensation; Difficu... | Recovered/Normal |
| Jun 2, 2017 | Human | Unknown | Carprofen | Eye irritation | Recovered/Normal |
| Jun 1, 2017 | Human | Unknown | Spinosad; Milbemycin Oxime | Gum pain; Wheezing; Breathing difficulty; Accidental exposure | Ongoing |
| Jun 1, 2017 | Human | Unknown | Doramectin | Blood in vomit; General illness | Outcome Unknown |
| Jun 1, 2017 | Human | Unknown | Spinosad; Milbemycin Oxime | Disoriented state; Accidental exposure | Recovered/Normal |
| May 30, 2017 | Human | Unknown | Moxidectin | Injection site bleeding; Injection site reddening | Outcome Unknown |
| May 30, 2017 | Human | Unknown | Oxytetracycline Dihydrate (Oxytetracy... | Injection site reaction NOS | Outcome Unknown |
| May 30, 2017 | Human | Unknown | Oclacitinib Maleate | Unclassifiable adverse event | Outcome Unknown |
| May 29, 2017 | Human | Unknown | Imidacloprid; Moxidectin | Pruritus; Welt; Throat constriction; Nasal cavity and sinus disorder NOS; Lip... | Outcome Unknown |
| May 29, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS | Recovered/Normal |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe, difficulty breathing, seizures, collapse, or severe swelling, seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.